Pain Management and Telemedicine: A Look at the COVID Experience and Beyond
COVID-19 caused a drastic change in clinical medicine around the globe. In the United States, telemedicine was rapidly adopted on a wide scale to minimize direct patient interaction and to reduce the spread of the COVID-19 virus. Telemedicine also went hand in hand with the rapid movement of working remotely. This has provided several challenges to chronic pain management clinics along with other subspecialties. Telemedicine has also opened opportunities for providing valuable care for patients with significant barriers to healthcare professionals. Given the benefits and downfalls of telemedicine, it is ultimately up to the provider who has an established patient-physician relationship and best understands the patient’s limitations and healthcare needs who can best determine which patient population telemedicine is appropriate for and how frequently it can be utilized for each individual patient.
1. Chauhan V, Galwankar S, Arquilla B, et al. Novel Coronavirus (COVID-19): Leveraging Telemedicine to Optimize Care While Minimizing Exposures and Viral Transmission. J Emerg Trauma Shock. 2020;13(1):20-24.
2. Mihalj M, Carrel T, Gregoric ID, et al. Telemedicine for preoperative assessment during a COVID-19 pandemic: Recommendations for clinical care. Best Pract Res Clin Anaesthesiol. 2020;34(2):345-351. doi:10.1016/j.bpa.2020.05.001
3. Charles BL. Telemedicine can lower costs and improve access. Healthc Financ Manage. 2000;54(4):66-69.
4. Hasoon J, Al-Jumah R, Urits I, et al. COVID-19 Numbers in Massachusetts and Changes Implemented at Beth Israel Deaconess Medical Center Department of Pain Medicine. Pain Phys. 2020;23(4S):S467-S468. doi:10.36076/ppj.2020/23/s467
5. Burroughs M, Urits I, Viswanath O, Simopoulos T, Hasoon J. Benefits and shortcomings of utilizing telemedicine during the COVID-19 pandemic. Proc (Bayl Univ Med Cent). 2020;33(4):699-700. doi:10.1080/08998280.2020.1792728
6. Hasoon J, Burroughs M, Urits I, Orhurhu V, Viswanath O, Kaye AD. COVID-19 and the Impact on Fellowship Education. Pain Phys. 2020;23(4S):S453-S454. doi:10.36076/ppj.2020/23/s467
7. Dalal S, Chitmeni A, Berger AA, et al. Buprenorphine for Chronic Pain: A Safer Alternative to Traditional Opioids. Health Psychol Res. 2021;9(1):27241. doi:10.52965/001c.27241
8. Edinoff AN, Kaufman SE, Chauncy TM, et al. Addiction and COVID: Issues, Challenges, and New Telehealth Approaches. Psychiatry International. 2022;3(2):169-180. doi:10.3390/psychiatryint3020014